Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |